2017 Macula Society 40th Annual Meeting

This educational activity is designed to improve patient care and to promote innovative research to push the field forward through reporting of the latest findings from multi-center clinical trials, discussion of investigator initiated studies, and the sharing of the cutting-edge research findings among the Macula Society members and guests.

The Macula Society was founded in 1977 as a society for vitreoretinal physicians, surgeons and researchers to gather, learn, and discuss the new frontiers in retinal surgery, clinical care and treatment and research studies. Annual meetings of the Macula Society provide a forum for reporting on the most innovative research, clinical experience and the latest clinical trial findings in the areas of retinal, macular and vitreous diseases and surgery, and for spirited discussions about new and possibly controversial treatment modalities.


ACCME Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Medical College of Wisconsin and The Macula Society. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this Live Activity for a maximum of 16.00 AMA PRA Category 1 Credit(s) ™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 16.00 hours of participation for continuing education for allied health professionals.

This meeting was supported by an unrestricted educational grant from:  Alcon lLaboratories, Clearside Biomedical, Heidelberg Engineering amd Bausch & Lomb



Course details

Target audience

Vitreoretinal specialists and surgeons-members of the Society; and Co-authors who are researchers, fellows, and ophthalmologists

Learning objectives

At the conclusion of this activity, I will be able to:
  1. Discuss findings from recently completed multi-center clinical trials in retina
  2. Appraise the efficacy and safety results for clinical studies investigating available and emerging treatment options and treatment modalities for macular diseases
  3. Implement best practices for these disease states based upon an evaluation of clinical trials, investigator initiated studies, and diagnostic and imaging technologies


Shangri-La Hotel
22 Orange Grove Road
South East Asia 258350

Faculty & credentials

Program Committee
Judy E. Kim, MD Chair
Caroline R. Baumal, MD
R.V. Paul Chan, MD, MSc, FACS
Craig M. Greven, MD
Jennifer I. Lim, MD
Lawrence J. Singerman, MD
Andrew P. Schachat, MD
In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships.  These relationships were reviewed via the MCW conflict of interest resolution process and resolved.  
ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Systems-based Practice
Barriers to change: 
1. The pace and volume of new information relevant to the field make it difficult to assimilate state of the art information into clinical practice. 2. Despite the sheer volume on new information, there may is often insufficient information to make informed decisions among the available options (eg. lack of comparative treatment trials). 3. The highly technical nature of new information in certain diagnostic and therapeutic modalities (eg progress in diagnosis and treatment of hereditary retinal diseases) is daunting to many clinicians.

CME Coordinator Contact Information

Stacy Singerman
Phone Number:: 
+1 (216) 839-4949
This live activity started on June 7th, 2017 and is no longer available for enrollments.